Cargando…
Single-dose Ag85B-ESAT6–loaded poly(lactic-co-glycolic acid) nanoparticles confer protective immunity against tuberculosis
BACKGROUND: Bacillus Calmette–Guérin, the attenuated strain of Mycobacterium bovis, remains the only available vaccine against tuberculosis (TB). However, its ineffectiveness in adults against pulmonary TB and varied protective efficacy (0–80%) speak to an urgent need for the development of an impro...
Autores principales: | Malik, Anshu, Gupta, Manish, Mani, Rajesh, Bhatnagar, Rakesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501725/ https://www.ncbi.nlm.nih.gov/pubmed/31118627 http://dx.doi.org/10.2147/IJN.S172391 |
Ejemplares similares
-
Ag85A/ESAT-6 chimeric DNA vaccine induces an adverse response in tuberculosis-infected mice
por: Liang, Yan, et al.
Publicado: (2016) -
ESAT-6 and Ag85A Synthetic Peptides as Candidates for an Immunodiagnostic Test in Children with a Clinical Suspicion of Tuberculosis
por: Araujo, Zaida, et al.
Publicado: (2021) -
Characterisation of a live Salmonella vaccine stably expressing the Mycobacterium tuberculosis Ag85B–ESAT6 fusion protein
por: Hall, Lindsay J., et al.
Publicado: (2009) -
Comparison of the Predicted Population Coverage of Tuberculosis Vaccine Candidates Ag85B-ESAT-6, Ag85B-TB10.4, and Mtb72f via a Bioinformatics Approach
por: Davila, Jose, et al.
Publicado: (2012) -
Human T Cell and Antibody-Mediated Responses to the Mycobacterium tuberculosis Recombinant 85A, 85B, and ESAT-6 Antigens
por: Macedo, Gilson C., et al.
Publicado: (2011)